JOHNSON & JOHNSON — Director's Dealing 2025

Feb 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-02-25

Reporting Person: Decker Robert J (VP Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-25	Common Stock	M	6999	$101.87	Acquired	28000	Direct
2025-02-25	Common Stock	S	6999	$165.88	Disposed	21001	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-25	Employee Stock Options (Right to Buy)	$101.87	M	6999	Disposed	2026-02-08	Common Stock (6999)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	620	Indirect
Common Stock	134	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $165.88 to $165.895. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).

F3: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).

F4: Vested and exercisable on the third anniversary of the date of the grant.